Vascular Biology in Clinical Practice © Vol. 6, No. 2
• High-dose statins and early benefit in ACS: Role of inflammation
This monograph, High-dose statins and early benefit in ACS: Role of inflammation
, is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine. Co-editors are Carl J. Pepine, MD, University of Florida College of Medicine, and Andrew P. Selwyn, MD, Professor of Medicine, Harvard Medical School.
Acute coronary syndromes (ACS), a major cause of hospitalization in this country, is most often caused by plaque erosion or rupture leading to formation of an occlusive thrombus. Emerging data suggest that patients with ACS may derive benefit from aggressive statin treatment. Importantly, benefit may become evident early, within weeks. This monograph discusses the biological and physical interactions that, potentially, may be responsible for rapid passivation of disrupted or vulnerable plaques.
The contents of this monograph express the views of the
individual contributors and do not necessarily reflect the views or
recommendations of the University of Florida College of Medicine,
Harvard Medical School, or the publisher. The reader is advised to
consult the full prescribing information for all medications prior to use.
Supported by an educational grant from Pfizer Inc.
© 2004 Medical Education Consultants, LLCSM (MEDCON).
All rights reserved.